Skip to content
10-Q

Quarterly Report

CHEMBIO DIAGNOSTICS, INC.

0001140361-22-017906

← back to feed
Filed
May 5, 2022 12:00 AM ET
Period of report
—

On SEC.gov

Filing index ↗

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2022 · Apr 29, 2022 30.22M sh
Shares Diluted Q1 2022 · Mar 31, 2022 30.09M sh
Shares Diluted Q1 2022 · Mar 31, 2021 20.16M sh
Operating Cash Flow Q1 2022 · Mar 31, 2022 −$4.37M
Operating Cash Flow Q1 2022 · Mar 31, 2021 −$7.26M
Short Term Debt Q1 2022 · Mar 31, 2022 $2.1M
Short Term Debt Q1 2022 · Dec 31, 2021 $1.2M
Cash And Equivalents Q1 2022 · Mar 31, 2022 $24.4M
Cash And Equivalents Q1 2022 · Dec 31, 2021 $28.77M
Stockholders Equity Q1 2022 · Mar 31, 2022 $26.54M
Stockholders Equity Q1 2022 · Dec 31, 2021 $34.26M
Stockholders Equity Q1 2022 · Mar 31, 2021 $23.29M
Stockholders Equity Q1 2022 · Dec 31, 2020 $27.78M
Current Liabilities Q1 2022 · Mar 31, 2022 $13.63M
Current Liabilities Q1 2022 · Dec 31, 2021 $15.28M
Total Liabilities Q1 2022 · Mar 31, 2022 $36.36M
Total Liabilities Q1 2022 · Dec 31, 2021 $38.99M
Current Assets Q1 2022 · Mar 31, 2022 $48.22M
Current Assets Q1 2022 · Dec 31, 2021 $55.23M
Total Assets Q1 2022 · Mar 31, 2022 $62.89M
Total Assets Q1 2022 · Dec 31, 2021 $73.25M
Eps Diluted Q1 2022 · Mar 31, 2022 −$0.29
Eps Diluted Q1 2022 · Mar 31, 2021 −$0.22
Eps Basic Q1 2022 · Mar 31, 2022 −$0.29
Eps Basic Q1 2022 · Mar 31, 2021 −$0.22
Sga Expense Q1 2022 · Mar 31, 2022 $6.95M
Sga Expense Q1 2022 · Mar 31, 2021 $6.09M
Rd Expense Q1 2022 · Mar 31, 2022 $1.65M
Rd Expense Q1 2022 · Mar 31, 2021 $2.86M
Net Income Q1 2022 · Mar 31, 2022 −$8.79M
Net Income Q1 2022 · Mar 31, 2021 −$4.5M
Operating Income Q1 2022 · Mar 31, 2022 −$8.05M
Operating Income Q1 2022 · Mar 31, 2021 −$3.86M
Cost Of Revenue Q1 2022 · Mar 31, 2022 $15.22M
Cost Of Revenue Q1 2022 · Mar 31, 2021 $3.55M
Revenue Q1 2022 · Mar 31, 2022 $18.82M
Revenue Q1 2022 · Mar 31, 2021 $8.72M